Even in Denmark — Novo Nordisk's dwelling current market — an application for Wegovy to obtain public health and fitness coverage coverage was turned down to the grounds that its cost was incommensurate with its therapeutic benefit.Our digital method of Health care involves every little thing from prognosis to writing prescriptions — and deli